Invention Grant
- Patent Title: Use of recombinant human calcineurin B subunit
-
Application No.: US16020363Application Date: 2018-06-27
-
Publication No.: US10646553B2Publication Date: 2020-05-12
- Inventor: Kesheng Han , Jian Fu , Zongwen Huang , Shuhong Tian , Lifang Han
- Applicant: HAIKOU QILI PHARMACEUTICAL CO., LTD.
- Applicant Address: CN Haikou, Hainan
- Assignee: HAIKOU QILI PHARMACEUTICAL CO., LTD.
- Current Assignee: HAIKOU QILI PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Haikou, Hainan
- Agency: Apex Attorneys at Law, LLP
- Agent Yue (Robert) Xu
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@77394a2f
- Main IPC: A61K38/46
- IPC: A61K38/46 ; A61K9/00 ; A61P35/04 ; A61K9/08
Abstract:
Provided is a use of a recombinant human calcineurin B subunit (rhCNB) in the preparation of a medicine for killing and/or inhibiting the gastric cancer.
Public/Granted literature
- US20180311320A1 USE OF RECOMBINANT HUMAN CALCINEURIN B SUBUNIT Public/Granted day:2018-11-01
Information query
IPC分类:
